Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Senile plaques accumulate over the course of decades in the brains of patients with Alzheimer's disease. A fundamental tenet of the amyloid hypothesis of Alzheimer's disease is that the deposition of amyloid-beta precedes and induces the neuronal abnormalities that underlie dementia. This idea has been challenged, however, by the suggestion that alterations in axonal trafficking and morphological abnormalities precede and lead to senile plaques. The role of microglia in accelerating or retarding these processes has been uncertain. To investigate the temporal relation between plaque formation and the changes in local neuritic architecture, we used longitudinal in vivo multiphoton microscopy to sequentially image young APPswe/PS1d9xYFP (B6C3-YFP) transgenic mice. Here we show that plaques form extraordinarily quickly, over 24 h. Within 1-2 days of a new plaque's appearance, microglia are activated and recruited to the site. Progressive neuritic changes ensue, leading to increasingly dysmorphic neurites over the next days to weeks. These data establish plaques as a critical mediator of neuritic pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, the nidus of Aβ plaques develops from within neurites at a time course that could also fit that of plaque formation determined by multiphoton microscopy (MPM) occurring within a day [120].”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [120]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the AD brain, microglia accumulate at the site of newly formed A deposits via migration or local proliferation and may help restrict plaque growth.4,5”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the brains of AD patients and APP-overexpressing mice, plaques are surrounded by reactive microglia and astrocytes (Meyer-Luehmann et al., 2008; Serrano-Pozo et al., 2013)”
From NHE6 depletion corrects ApoE4-mediated synaptic impairments and reduces amyloid plaque load (2021) · cites this paper as Meyer-Luehmann et al., 2008
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Microglia appear rapidly (within one day) at the site of newly formed plaques [78].”
From Microglial dysfunction in brain aging and Alzheimer's disease (2014) · cites this paper as [78]
The cited source says what the claim attributes to it.
In the citing paper
“Remarkably, this MPM study of AD transgenic mouse brain in vivo also described the emergence of dystrophic neurites in areas distant from plaques that appeared and, at times, even disappeared, although intraneuronal Aβ was not examined in these neurites.”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [120]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 1×
“It is possible that submicroscopic nuclei may be present in the cortex 23 , perhaps related to the recently reported amyloid-β oligomeric forms 24,25 , as precursors to this sudden growth.”
BackgroundRetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · cited 2×
“These data thus lead to a model consistent with a prediction of the amyloid hypothesis in which amyloid deposition, activation and recruitment of microglia and local neuritic changes play out as a sequential cascade leading to neurodegeneration 1 .”
BackgroundResultWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · cited 1×
“It is possible that submicroscopic nuclei may be present in the cortex 23 , perhaps related to the recently reported amyloid-β oligomeric forms 24,25 , as precursors to this sudden growth.”
BackgroundCorrelative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · cited 3×
“To examine whether the phenotype of plaque formation in as short a period as one week was unique to the aggressive APP/PS1 transgenic mouse model, we used a mouse line that has a slower progression of disease (Tg2576) 7 .”
BackgroundMethodImmunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Jung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · cited 3×
“In addition, homozygous PDAPP mice 16 were crossed with homozygous CX3CR1-GFP mice 17 , and two female PDAPP +/ − ×CX3CR1-GFP +/ − transgenic mice at the age of 18 months were used in this study and imaged for three consecutive days.”
BackgroundMethodJarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178 · cited 1×
“These results are surprising because it has been generally accepted, based on in vitro studies of protein aggregation, that amyloid-β aggregation is time dependent and follows a relatively slow nucleation-dependent polymerization process 22 .”
ResultJankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265 · cited 1×
“It has been proposed that activated microglia clear amyloid deposits 13 , are the nidus for initiation of amyloid fibrils 14 or restrict plaques 15 .”
Background
Cited by
Items 101–200 of 995
Fonseca, M. I., Ager, R. R., Chu, S.-H., Yazan, O., Sanderson, S. D., LaFerla, F. M., Taylor, S. M., Woodruff, T. M., & Tenner, A. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901005 · Cited by 268
“formed fibrillar plaques in mouse models (17), it can be hypoth-”
BackgroundGenes and pathways underlying regional and cell type changes in Alzheimer’s disease
Miller, J. A., Woltjer, R. L., Goodenbour, J. M., Horvath, S., & Geschwind, D. H. (2013) · Genome Medicine · doi:10.1186/gm452 · Cited by 275
“Furthermore, it is widely accepted that microglia often are found near amyloid deposits [15] and that microglia-mediated inflammation contributes to the progression of AD [56].”
BackgroundInfluentialKim, J., Castellano, J. M., Jiang, H., Basak, J. M., Parsadanian, M., Pham, V., Mason, S. M., Paul, S. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.11.013 · Cited by 308
“Previous studies suggest that fibrillar amyloid plaques may trigger neuroinflammatory cascades (Meyer-Luehmann et al., 2008).”
Self-citationSong, M., Jin, J., Lim, J.-E., Kou, J., Pattanayak, A., Rehman, J. A., Kim, H.-D., Tahara, K., Lalonde, R., & Fukuchi, K.-I. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-92 · Cited by 273
Reviews: Current Concepts in Alzheimer's Disease: A Multidisciplinary Review
Minati, L., Edginton, T., Grazia Bruzzone, M., & Giaccone, G. (2009) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317508328602 · Cited by 268
“Fibrillary forms were originally believed to be the primary neurotoxic species but in recent years evidence on the toxicity of Abeta oligomers has also accumulated.(36) Although we do have evidence of Abeta toxicity in vitro and in vivo, single-transgenic mouse models of AD, despite massive accumulation, do not robust…”
BackgroundCharacterizing the Appearance and Growth of Amyloid Plaques in APP/PS1 Mice
Yan, P., Bero, A. W., Cirrito, J. R., Xiao, Q., Hu, X., Wang, Y., Gonzales, E., Holtzman, D. M., & Lee, J.-M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2637-09.2009 · Cited by 264
“Open-skull cranial windows were prepared on the day of the first imaging session as previously described (Bolmont et al., 2008; Meyer-Luehmann et al., 2008).”
MethodResultInfluentialSelf-citationRole of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target
Du, L., Zhang, Y., Chen, Y., Zhu, J., Yang, Y., & Zhang, H.-L. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0245-0 · Cited by 262
Immune aging, dysmetabolism, and inflammation in neurological diseases
Deleidi, M., Jäggle, M., & Rubino, G. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00172 · Cited by 260
“Amyloid deposition leads to microglial activation (Meyer-Luehmann et al., 2008) and the production of proinflammatory mediators that contribute to disease pathogenesis.”
BackgroundAPOE mediated neuroinflammation and neurodegeneration in Alzheimer’s disease
Parhizkar, S., & Holtzman, D. M. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101594 · Cited by 255
Self-citationTime-lapse imaging of disease progression in deep brain areas using fluorescence microendoscopy
Barretto, R. P. J., Ko, T. H., Jung, J. C., Wang, T. J., Capps, G., Waters, A. C., Ziv, Y., Attardo, A., Recht, L., & Schnitzer, M. J. (2011) · Nature Medicine · doi:10.1038/nm.2292 · Cited by 249
“There are already a large set of fluorescent markers of pertinence to disease studies, such as labels for amyloid plaques 10 , reactive oxygen species 9 , and glia and immune cells 11 , and many of these should be readily usable in combination with microendoscopy.”
Neurovascular Dysfunction and Faulty Amyloid -Peptide Clearance in Alzheimer Disease
Sagare, A. P., Bell, R. D., & Zlokovic, B. V. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011452 · Cited by 251
“…(Deane et al. 2003; Bell et al. 2009) and neuronal (Yan et al. 1996; Walsh et al. 2002; Takuma et al. 2009) dysfunction and promote self-propagation (Meyer-Luehmann et al. 2006, 2008; Eisele et al. 2010), as in prion diseases (Prusiner 1996), leading to cerebral b-amyloidosis (Zlokovic 2008).”
BackgroundThe NLRP3 Inflammasome in Alzheimer’s Disease
Tan, M.-S., Yu, J.-T., Jiang, T., Zhu, X.-C., & Tan, L. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8475-x · Cited by 248
Amyloid-β as a Modulator of Synaptic Plasticity
Parihar, M. S., & Brewer, G. J. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101020 · Cited by 247
“amyloid plaques is characterized by highly dysmorphic neurites and spine turnover [192,193] causing a net loss”
Genetic mouse models of brain ageing and Alzheimer's disease
Bilkei-Gorzo, A. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.12.009 · Cited by 248
“Using this line, it was possible to prove that formation of amyloid plaques is an early event in the pathogenic process preceding neuritic changes and neuroinflammation (Meyer-Luehmann et al., 2008).”
BackgroundAre NSAIDs useful to treat Alzheimer’s disease or mild cognitive impairment
Imbimbo (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00019 · Cited by 75
“Recent studies using in vivo imaging have demonstrated that microglia rapidly migrate to newly formed Aβ deposits in mouse models of AD but are not able to clear them but instead tend to stabilize the plaques avoiding further growth (Meyer-Luehmann et al., 2008; Bolmont et al., 2008).”
Kocahan, S., & Doğan, Z. (2017) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2017.15.1.1 · Cited by 233
Microglia and mast cells: two tracks on the road to neuroinflammation
Skaper, S. D., Giusti, P., & Facci, L. (2012) · The FASEB Journal · doi:10.1096/fj.11-197194 · Cited by 235
Baik, S. H., Kang, S., Son, S. M., & Mook-Jung, I. (2016) · Glia · doi:10.1002/glia.23074 · Cited by 234
“, 2011), and plaque formation certainly occurs in the brain (Meyer-Luehmann et al., 2008).”
BackgroundSoluble forms of tau are toxic in Alzheimer's disease
Kopeikina, K., Hyman, B., & Spires-Jones, T. (2012) · Translational Neuroscience · doi:10.2478/s13380-012-0032-y · Cited by 232
Self-citationPerez, S. E., Lumayag, S., Kovacs, B., Mufson, E. J., & Xu, S. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2384 · Cited by 230
Insulin Resistance and Diabetes Mellitus in Alzheimer’s Disease
Burillo, J., Marqués, P., Jiménez, B., González-Blanco, C., Benito, M., & Guillén, C. (2021) · Cells · doi:10.3390/cells10051236 · Cited by 225
Amyloid β-Protein Toxicity and the Pathogenesis of Alzheimer Disease
Yankner, B. A., & Lu, T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800018200 · Cited by 227
Shechter, R., & Schwartz, M. (2013) · The Journal of Pathology · doi:10.1002/path.4106 · Cited by 225
Tõugu, V., Tiiman, A., & Palumaa, P. (2011) · Metallomics · doi:10.1039/c0mt00073f · Cited by 225
Sanchez-Varo, R., Trujillo-Estrada, L., Sanchez-Mejias, E., Torres, M., Baglietto-Vargas, D., Moreno-Gonzalez, I., De Castro, V., Jimenez, S., Ruano, D., Vizuete, M., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0896-x · Cited by 222
“Whereas some authors have proposed that the appearance of dystrophic neurites precedes plaque formation [2, 23, 27, 56], a recent study using in vivo multiphoton imaging showed that dystrophies develop following amyloid deposition [42].”
BackgroundKumar, S., Rezaei‐Ghaleh, N., Terwel, D., Thal, D. R., Richard, M., Hoch, M., Mc Donald, J. M., Wüllner, U., Glebov, K., Heneka, M. T., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.138 · Cited by 219
Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function
Spiteri, A. G., Wishart, C. L., Pamphlett, R., Locatelli, G., & King, N. J. C. (2022) · Acta Neuropathologica · doi:10.1007/s00401-021-02384-2 · Cited by 244
“Both in human AD and its mouse models, microglia surround Aβ plaques [216, 226, 365].”
BackgroundSchmid, L. C., Mittag, M., Poll, S., Steffen, J., Wagner, J., Geis, H.-R., Schwarz, I., Schmidt, B., Schwarz, M. K., Remy, S., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.08.034 · Cited by 213
“Increased synapse loss as well as aberrant structural remodeling of synapses and dendrites have been detected in proximity to amyloidbeta (Ab) plaques, a major hallmark of AD (Bittner et al., 2010, 2012; Liebscher et al., 2014; Meyer-Luehmann et al., 2008; Spires et al., 2005; Spires-Jones et al., 2007; Tsai et al., 2…”
BackgroundMicroglia contribute to the propagation of Aβ into unaffected brain tissue
d’Errico, P., Ziegler-Waldkirch, S., Aires, V., Hoffmann, P., Mezö, C., Erny, D., Monasor, L. S., Liebscher, S., Ravi, V. M., Joseph, K., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-021-00951-0 · Cited by 214
Self-citationChemical Fluorescent Probe for Detection of Aβ Oligomers
Teoh, C. L., Su, D., Sahu, S., Yun, S.-W., Drummond, E., Prelli, F., Lim, S., Cho, S., Ham, S., Wisniewski, T., et al. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b06190 · Cited by 209
TiO2 nanoparticles promote β-amyloid fibrillation in vitro
Wu, W.-H., Sun, X., Yu, Y.-P., Hu, J., Zhao, L., Liu, Q., Zhao, Y.-F., & Li, Y.-M. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.035 · Cited by 205
Roche, J., Shen, Y., Lee, J. H., Ying, J., & Bax, A. (2016) · Biochemistry · doi:10.1021/acs.biochem.5b01259 · Cited by 203
Cortes, C. J., & La Spada, A. R. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.05.012 · Cited by 202
“Microglia, the resident macrophages of the CNS, play a key role in surveying the brain and are recruited to sites of amyloid plaque deposition in AD (Meyer-Luehmann et al., 2008).”
BackgroundSarell, C. J., Wilkinson, S. R., & Viles, J. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.171355 · Cited by 199
Koronyo, Y., Salumbides, B. C., Black, K. L., & Koronyo-Hamaoui, M. (2012) · Neurodegenerative Diseases · doi:10.1159/000335154 · Cited by 196
Ji, M., Arbel, M., Zhang, L., Freudiger, C. W., Hou, S. S., Lin, D., Yang, X., Bacskai, B. J., & Xie, X. S. (2018) · Science Advances · doi:10.1126/sciadv.aat7715 · Cited by 197
Self-citationDirect three-dimensional visualization of membrane disruption by amyloid fibrils
Milanesi, L., Sheynis, T., Xue, W.-F., Orlova, E. V., Hellewell, A. L., Jelinek, R., Hewitt, E. W., Radford, S. E., & Saibil, H. R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206325109 · Cited by 194
Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition
Rodriguez, G. A., Tai, L. M., LaDu, M. J., & Rebeck, G. W. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-111 · Cited by 193
“clinical symptoms of AD correlate closely with neuronal damage, stemming in part by Aβ-driven neuroinflammatory responses [8,9].”
BackgroundCerebrovascular lesions induce transient -amyloid deposition
Garcia-Alloza, M., Gregory, J., Kuchibhotla, K. V., Fine, S., Wei, Y., Ayata, C., Frosch, M. P., Greenberg, S. M., & Bacskai, B. J. (2011) · Brain · doi:10.1093/brain/awr300 · Cited by 187
“The increase in the amyloid burden was the result of the generation of new plaques, and not the growth of existing plaques in concordance with previous observations (Garcia-Alloza et al., 2006; Meyer-Luehmann et al., 2008).”
ResultSelf-citationChronic in vivo imaging in the mouse spinal cord using an implanted chamber
Farrar, M. J., Bernstein, I. M., Schlafer, D. H., Cleland, T. A., Fetcho, J. R., & Schaffer, C. B. (2012) · Nature Methods · doi:10.1038/nmeth.1856 · Cited by 188
“(4) np g © 2 01 2 N at ur e A m er ic a, In c.”
Ferrero, J., Williams, L., Stella, H., Leitermann, K., Mikulskis, A., O'Gorman, J., & Sevigny, J. (2016) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2016.06.002 · Cited by 189
Inflammasome signaling at the heart of central nervous system pathology
Chakraborty, S., Kaushik, D. K., Gupta, M., & Basu, A. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22343 · Cited by 187
“…molecules occur in deposits at various sites of inflammation in the CNS. Senile neuritic plaques in AD secrete neurotoxic factors and recruit microglia (Meyer-Luehmann et al., 2008) that phagocytose Ab aggregates (Simard et al., 2006) and secrete cytokines post activation (Itagaki et al., 1989).”
BackgroundThe link between chronic pain and Alzheimer’s disease
Cao, S., Fisher, D. W., Yu, T., & Dong, H. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1608-z · Cited by 181
“both humans [112] and AD mice [113] and have been shown to regulate plaque dynamics [114].”
BackgroundMitochondrial alterations near amyloid plaques in an Alzheimer’s disease mouse model
Xie, H., Guan, J., Borrelli, L. A., Xu, J., Serrano-Pozo, A., & Bacskai, B. J. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1836-13.2013 · Cited by 185
“This halo corresponds well with previous reports demonstrating local alterations in spine density, neuritic curvature, calcium dysregulation, and oxidative stress (Spires et al., 2005; Kuchibhotla et al., 2008; Meyer-Luehmann et al., 2008; Koffie et al., 2009; Xie et al., 2013).”
Self-citationEffects of in vivo conditions on amyloid aggregation
Owen, M. C., Gnutt, D., Gao, M., Wärmländer, S. K. T. S., Jarvet, J., Gräslund, A., Winter, R., Ebbinghaus, S., & Strodel, B. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00034d · Cited by 182
Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders
Salvadores, N., Sanhueza, M., Manque, P., & Court, F. A. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00451 · Cited by 182
“, 2017), and abnormal calcium signaling (Mattson et al., 1992; Furukawa et al., 1996; Demuro et al., 2005; Meyer-Luehmann et al., 2008).”
BackgroundTau protein and tau aggregation inhibitors
Bulic, B., Pickhardt, M., Mandelkow, E.-M., & Mandelkow, E. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.01.016 · Cited by 180
Bidirectional Relationship between Functional Connectivity and Amyloid-β Deposition in Mouse Brain
Bero, A. W., Bauer, A. Q., Stewart, F. R., White, B. R., Cirrito, J. R., Raichle, M. E., Culver, J. P., & Holtzman, D. M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5845-11.2012 · Cited by 181
Self-citationMechanisms of Pathogenic Tau and Aβ Protein Spreading in Alzheimer’s Disease
d‘Errico, P., & Meyer-Luehmann, M. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00265 · Cited by 175
“Albeit in vivo studies demonstrated that Aβ plaques lead to neuronal loss, neuronal dystrophy and alters their normal neuritic functionality (Meyer-Luehmann et al., 2008, 2009; Shah et al., 2010), different studies have identified soluble oligomeric Aβ species as the toxic drivers responsible for…”
BackgroundSelf-citationThe complement cascade: Yin-Yang in neuroinflammation—neuro-protection and -degeneration
Alexander, J. J., Anderson, A. J., Barnum, S. R., Stevens, B., & Tenner, A. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05668.x · Cited by 177
“Recent application of intravital microscopy to image one such APP mouse model demonstrated that the appearance of fibrillar amyloid plaques was rapidly followed by an influx of microglia and subsequent degeneration of neurons in the plaque area (Meyer-Luehmann et al. 2008).”
BackgroundMultiple Defects in Energy Metabolism in Alzheimers Disease
L. Ferreira, I., Resende, R., Ferreiro, E., C. Rego, A., & F. Pereira, C. (2010) · Current Drug Targets · doi:10.2174/1389450111007011193 · Cited by 177
“These receptors are concentrated on postsynaptic spines of neuronal dendrites and were shown to play an important role in decreased synaptic function observed in aging and early AD ([125-128], reviewed in [129]), thereby altering the ability of neurons to store information.”
BackgroundAmyloid β-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin
Malito, E., Hulse, R. E., & Tang, W.-J. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8112-4 · Cited by 176
Development of Positron Emission Tomography β-Amyloid Plaque Imaging Agents
Mathis, C. A., Mason, N. S., Lopresti, B. J., & Klunk, W. E. (2012) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2012.07.001 · Cited by 175
Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies
Adalbert, R., Nogradi, A., Babetto, E., Janeckova, L., Walker, S. A., Kerschensteiner, M., Misgeld, T., & Coleman, M. P. (2009) · Brain · doi:10.1093/brain/awn312 · Cited by 177
Microglia Activation and Anti-inflammatory Regulation in Alzheimer’s Disease
Lue, L.-F., Kuo, Y.-M., Beach, T., & Walker, D. G. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8106-8 · Cited by 176
Young microglia restore amyloid plaque clearance of aged microglia
Daria, A., Colombo, A., Llovera, G., Hampel, H., Willem, M., Liesz, A., Haass, C., & Tahirovic, S. (2017) · The EMBO Journal · doi:10.15252/embj.201694591 · Cited by 174
Rapid cell death is preceded by amyloid plaque-mediated oxidative stress
Xie, H., Hou, S., Jiang, J., Sekutowicz, M., Kelly, J., & Bacskai, B. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217938110 · Cited by 172
“oxidative injury produced by the Alzheimer’s beta-amyloid peptide (1-40) in cultured”
BackgroundSelf-citationMicroglial activation in Alzheimer's disease: an (R)-[11C]PK11195 positron emission tomography study
Schuitemaker, A., Kropholler, M. A., Boellaard, R., van der Flier, W. M., Kloet, R. W., van der Doef, T. F., Knol, D. L., Windhorst, A. D., Luurtsema, G., Barkhof, F., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.04.021 · Cited by 171
“As clinicopathological and animal studies have demonstrated that microglia are attracted to the site of amyloid plaque formation (Arends et al., 2000; Meyer-Luehmann et al., 2008), one could expect increased (R)-[(11)C]PK11195 binding in regions with reported A deposition.”
BackgroundMechanisms of microglia accumulation in Alzheimer’s disease: therapeutic implications
Khoury, J. E., & Luster, A. D. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.08.004 · Cited by 171
Interactions between APP secretases and inflammatory mediators
Sastre, M., Walter, J., & Gentleman, S. M. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-25 · Cited by 171
Kaminski Schierle, G. S., van de Linde, S., Erdelyi, M., Esbjörner, E. K., Klein, T., Rees, E., Bertoncini, C. W., Dobson, C. M., Sauer, M., & Kaminski, C. F. (2011) · Journal of the American Chemical Society · doi:10.1021/ja201651w · Cited by 171
Imaging Microglial Activation During Neuroinflammation and Alzheimer’s Disease
Venneti, S., Wiley, C. A., & Kofler, J. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9142-2 · Cited by 170
“protein permits studying microglial–neuronal interaction in vivo (Meyer-Luehmann et al. 2008).”
BackgroundInfluentialVan Zeller, M., Dias, D., Sebastião, A. M., & Valente, C. A. (2021) · Journal of Alzheimer's Disease · doi:10.3233/jad-210268 · Cited by 169
Tau Oligomers: The Toxic Player at Synapses in Alzheimer’s Disease
Guerrero-Muñoz, M. J., Gerson, J., & Castillo-Carranza, D. L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00464 · Cited by 168
“The overexpression of Aβ in mice revealed neurite degeneration after plaque formation (Meyer-Luehmann et al., 2008).”
BackgroundDá Mesquita, S., Ferreira, A. C., Sousa, J. C., Correia-Neves, M., Sousa, N., & Marques, F. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.014 · Cited by 166
Mizuno, T., Doi, Y., Mizoguchi, H., Jin, S., Noda, M., Sonobe, Y., Takeuchi, H., & Suzumura, A. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.06.011 · Cited by 159
Serrano-Pozo, A., William, C. M., Ferrer, I., Uro-Coste, E., Delisle, M.-B., Maurage, C.-A., Hock, C., Nitsch, R. M., Masliah, E., Growdon, J. H., et al. (2010) · Brain · doi:10.1093/brain/awq056 · Cited by 159
“In addition, in vivo imaging of the brain in one of these models revealed that changes in neurite trajectories follow the appearance of new plaques, arguing that this morphologic change is secondary to Ab deposition (Meyer-Luehmann et al., 2008).”
BackgroundSelf-citationLarger temporal volume in elderly with high versus low beta-amyloid deposition
Chételat, G., Villemagne, V. L., Pike, K. E., Baron, J.-C., Bourgeat, P., Jones, G., Faux, N. G., Ellis, K. A., Salvado, O., Szoeke, C., et al. (2010) · Brain · doi:10.1093/brain/awq187 · Cited by 159
Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease
Yao, J., Ho, D., Calingasan, N. Y., Pipalia, N. H., Lin, M. T., & Beal, M. F. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20121239 · Cited by 159
“Previous studies suggested that amyloid plaques may trigger neuroinflammatory cascades (Meyer-Luehmann et al., 2008).”
BackgroundGlial calcium and diseases of the nervous system
Nedergaard, M., Rodríguez, J. J., & Verkhratsky, A. (2010) · Cell Calcium · doi:10.1016/j.ceca.2009.11.010 · Cited by 158
The synapse as a treatment avenue for Alzheimer’s Disease
Peng, L., Bestard‐Lorigados, I., & Song, W. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01565-z · Cited by 180
Role for Reelin in stabilizing cortical architecture
Frotscher, M. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.06.001 · Cited by 157
Accumulation of tau induced in neurites by microglial proinflammatory mediators
Gorlovoy, P., Larionov, S., Pham, T. T. H., & Neumann, H. (2009) · The FASEB Journal · doi:10.1096/fj.08-123877 · Cited by 156
“Another group elucidated the role of microglia in accelerating the disease process in the APP/PS1 transgenic animal model of AD (20).”
BackgroundInfluentialBao, J., Zheng, L., Zhang, Q., Li, X., Zhang, X., Li, Z., Bai, X., Zhang, Z., Huo, W., Zhao, X., et al. (2016) · Protein & Cell · doi:10.1007/s13238-016-0269-2 · Cited by 156
Microglia limit the expansion of β-amyloid plaques in a mouse model of Alzheimer’s disease
Zhao, R., Hu, W., Tsai, J., Li, W., & Gan, W.-B. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0188-6 · Cited by 151
Lipid changes in the aged brain: Effect on synaptic function and neuronal survival
Ledesma, M. D., Martín, M. G., & Dotti, C. G. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.11.004 · Cited by 171
Koenigsknecht-Talboo, J., Meyer-Luehmann, M., Parsadanian, M., Garcia-Alloza, M., Finn, M. B., Hyman, B. T., Bacskai, B. J., & Holtzman, D. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4147-08.2008 · Cited by 149
“It was recently demonstrated that microglial cells move toward newly formed plaques within 24 h of plaque formation (Meyer-Luehmann et al., 2008) as well as toward existing plaques over the course of 24 h (Bolmont et al., 2008).”
BackgroundSelf-citationRelevance of Transgenic Mouse Models to Human Alzheimer Disease
Morrissette, D. A., Parachikova, A., Green, K. N., & LaFerla, F. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800030200 · Cited by 147
Role of microglia in neuronal degeneration and regeneration
Walter, L. M., & Neumann, H. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0180-5 · Cited by 168
Filippini, N., Rao, A., Wetten, S., Gibson, R. A., Borrie, M., Guzman, D., Kertesz, A., Loy-English, I., Williams, J., Nichols, T., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.10.003 · Cited by 143
Proteinopathies, a core concept for understanding and ultimately treating degenerative disorders?
Bayer, T. A. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.03.007 · Cited by 140
“However, recent findings might implicate a prion-like spread of misfolded proteins also in AD (Meyer-Luehmann et al., 2008) and PD (Kordower et al.”
BackgroundBone-marrow-derived microglia: myth or reality?
Soulet, D., & Rivest, S. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.04.002 · Cited by 139
Chaperone signalling complexes in Alzheimer's disease
Koren, J., Jinwal, U. K., Lee, D. C., Jones, J. R., Shults, C. L., Johnson, A. G., Anderson, L. J., & Dickey, C. A. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00557.x · Cited by 138
“As enough of this material is produced, amyloid plaques form spontaneously and remain quite stable over time [18, 19].”
BackgroundAdvances in the pathogenesis of Alzheimer’s disease: a re-evaluation of amyloid cascade hypothesis
Dong, S., Duan, Y., Hu, Y., & Zhao, Z. (2012) · Translational Neurodegeneration · doi:10.1186/2047-9158-1-18 · Cited by 139
“Aβ and inflammation Microglia is rapidly recruited around amyloid plaques after its appearance [144].”
BackgroundDifferential cell proliferation in the cortex of the appsweps1de9 alzheimer's disease mouse model
Kamphuis, W., Orre, M., Kooijman, L., Dahmen, M., & Hol, E. M. (2012) · Glia · doi:10.1002/glia.22295 · Cited by 137
“Our findings are in keeping with observations that newly formed plaques recruit microglia leading to an increased local microglia density (Bolmont et al., 2008; Frautschy et al., 1998; Lee et al., 2010; Meyer-Luehmann et al., 2008; Ruan et al., 2009).”
ResultHefendehl, J. K., Wegenast-Braun, B. M., Liebig, C., Eicke, D., Milford, D., Calhoun, M. E., Kohsaka, S., Eichner, M., & Jucker, M. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5147-10.2011 · Cited by 138
“The appearance and development of -amyloid plaques has been previously addressed and yielded inconsistent results (Bolmont et al., 2008; Meyer-Luehmann et al., 2008; Yan et al., 2009).”
BackgroundResultStaged decline of neuronal function in vivo in an animal model of Alzheimer's disease
Grienberger, C., Rochefort, N. L., Adelsberger, H., Henning, H. A., Hill, D. N., Reichwald, J., Staufenbiel, M., & Konnerth, A. (2012) · Nature Communications · doi:10.1038/ncomms1783 · Cited by 138
Lietzén, N., Öhman, T., Rintahaka, J., Julkunen, I., Aittokallio, T., Matikainen, S., & Nyman, T. A. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001340 · Cited by 137
Imaging calcium signals in vivo: a powerful tool in physiology and pharmacology
Russell, J. T. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00988.x · Cited by 189
“A recent in vivo study of an Alzheimer’s disease mouse model revealed a number of new observations including rapid development local neuronal toxicity, appearance of dysmorphic neurites and microglial infiltration (Meyer-Luehmann et al., 2008).”
BackgroundFunctional and structural damage of neurons by innate immune mechanisms during neurodegeneration
Ising, C., & Heneka, M. T. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0153-x · Cited by 128
Diminished perisomatic GABAergic terminals on cortical neurons adjacent to amyloid plaques
Garcia-Marin, V. (2009) · Frontiers in Neuroanatomy · doi:10.3389/neuro.05.028.2009 · Cited by 136
Chloride intracellular channel 1 (CLIC1): Sensor and effector during oxidative stress
Averaimo, S., Milton, R. H., Duchen, M. R., & Mazzanti, M. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.02.073 · Cited by 153
“Microglia represent the immune effector cells of the CNS [11], where they play an important role protecting neurons from bacterial infections, inflammation, trauma, ischemic damage etc.”
BackgroundInfluentialDoi, Y., Mizuno, T., Maki, Y., Jin, S., Mizoguchi, H., Ikeyama, M., Doi, M., Michikawa, M., Takeuchi, H., & Suzumura, A. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090418 · Cited by 135
“Within 1 to 2 days of a new plaque’s appearance, microglia are activated and recruited to the site.(47) ICV injection of CpG may directly induce microglial activation via TLR9 and enhance microglial rapid uptake of oA through fluid-phase macropinocytosis as reported recently.”
BackgroundYang, J., Zhang, X., Yuan, P., Yang, J., Xu, Y., Grutzendler, J., Shao, Y., Moore, A., & Ran, C. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706248114 · Cited by 135
Thal, D. R., Griffin, W. S. T., & Braak, H. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00411.x · Cited by 134
“In APP-transgenic mice neuritic/dendritic degeneration has been observed in association with amyloid plaques as well as in the absence of A -deposits [51, 52, 72–74].”
BackgroundQuantitative proteomics reveals distinct composition of amyloid plaques in Alzheimer’s disease
Xiong, F., Ge, W., & Ma, C. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.10.006 · Cited by 133
Spines, plasticity, and cognition in Alzheimer's model mice
Spires-Jones, T., & Knafo, S. (2012) · Neural Plasticity · doi:10.1155/2012/319836 · Cited by 133
“This technique shows that plaques form rapidly, over the course of one day, and that within one week of plaque formation, surrounding dendrites begin to curve and exhibit dystrophic swellings [36].”
MethodSelf-citationInflammasomes: Molecular Regulation and Implications for Metabolic and Cognitive Diseases
Choi, A. J. S., & Ryter, S. W. (2014) · Molecules and Cells · doi:10.14348/molcells.2014.0104 · Cited by 131
The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects
Sleegers, K., Lambert, J.-C., Bertram, L., Cruts, M., Amouyel, P., & Van Broeckhoven, C. (2010) · Trends in Genetics · doi:10.1016/j.tig.2009.12.004 · Cited by 129
Spatial proteomics in three-dimensional intact specimens
Bhatia, H. S., Brunner, A.-D., Öztürk, F., Kapoor, S., Rong, Z., Mai, H., Thielert, M., Ali, M., Al-Maskari, R., Paetzold, J. C., et al. (2022) · Cell · doi:10.1016/j.cell.2022.11.021 · Cited by 129
Metadata
- Authors
- Meyer-Luehmann, M., Spires-Jones, T. L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., Koenigsknecht-Talboo, J., Holtzman, D. M., Bacskai, B. J., & Hyman, B. T.
- Affiliations
- Harvard University (US)
- Washington University in St. Louis (US)
- Corresponding author
- Hyman, Bradley T.
- Venue
- Nature
- Published
- 2008-02
- Volume
- 451
- Issue
- 7179
- Pages
- 720-724
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3264491
- OpenAlex
- W2107015337
- Cited by
- 987
- References
- 27
- Citations by year
- 2026: 27 · 2025: 25 · 2024: 45 · 2023: 38 · 2022: 45 · 2021: 56 · 2020: 43 · 2019: 40 · 2018: 37 · 2017: 36 · 2016: 57 · 2015: 51 · 2014: 48 · 2013: 62 · 2012: 83
- FWCI
- 66.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Alzheimer's Association
- University of Pittsburgh
- National Institutes of Health
- National Institute on Aging (R01AG008487, P50AG005134, P30AG062421)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK056341)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, amyloid plaques, microglial activation, microglial recruitment, APP/PS1 mice, amyloid hypothesis, cortical degeneration
- MeSH terms
- Alzheimer Disease, Animals, Axons, Disease Models, Animal, Mice, Transgenic, Time Factors, Amyloid beta-Peptides, Neurites, Microglia, Disease Progression, Mice, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.